Drugs / Kinezodianone R hydrochloride
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05389267 | Jul 2022 → Dec 2024 overdue | glaucoma, ocular hypertension | Laboratoires Thea | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kinezodianone R hydrochloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05389267 ↗ |
| Route | Other | “Eyedrops” NCT05389267 ↗ |